T0	KEYPHRASE-NOTYPES 0 8	Patients
T1	KEYPHRASE-NOTYPES 33 35	LM
T2	KEYPHRASE-NOTYPES 43 62	cerebrospinal fluid
T3	KEYPHRASE-NOTYPES 64 67	CSF
T4	KEYPHRASE-NOTYPES 69 80	examination
T5	KEYPHRASE-NOTYPES 91 108	white blood cells
T6	KEYPHRASE-NOTYPES 113 129	cubic millimeter
T7	KEYPHRASE-NOTYPES 131 147	nontraumatic tap
T8	KEYPHRASE-NOTYPES 162 178	erythema migrans
T9	KEYPHRASE-NOTYPES 180 182	EM
T10	KEYPHRASE-NOTYPES 191 213	positive Lyme serology
T11	KEYPHRASE-NOTYPES 215 230	Serologic tests
T12	KEYPHRASE-NOTYPES 278 288	laboratory
T13	KEYPHRASE-NOTYPES 313 323	techniques
T14	KEYPHRASE-NOTYPES 343 351	patients
T15	KEYPHRASE-NOTYPES 356 361	tests
T16	KEYPHRASE-NOTYPES 375 406	offsite commercial laboratories
T17	KEYPHRASE-NOTYPES 410 436	positive western blot test
T18	KEYPHRASE-NOTYPES 441 471	laboratory-determined criteria
T19	KEYPHRASE-NOTYPES 487 492	cases
T20	KEYPHRASE-NOTYPES 509 556	standardized western blot interpretive criteria
T21	KEYPHRASE-NOTYPES 583 591	evidence
T22	KEYPHRASE-NOTYPES 595 607	Lyme disease
T23	KEYPHRASE-NOTYPES 612 617	cases
T24	KEYPHRASE-NOTYPES 624 640	western blotting
T25	KEYPHRASE-NOTYPES 664 683	enzyme immunoassays
T26	KEYPHRASE-NOTYPES 700 714	true positives
T27	KEYPHRASE-NOTYPES 722 729	results
T28	KEYPHRASE-NOTYPES 764 769	limit
T29	KEYPHRASE-NOTYPES 775 790	reactive result
T30	KEYPHRASE-NOTYPES 792 794	VM
T31	KEYPHRASE-NOTYPES 823 840	CSF criteria
T32	KEYPHRASE-NOTYPES 845 853	addition
T33	KEYPHRASE-NOTYPES 857 880	laboratory confirmation
T34	KEYPHRASE-NOTYPES 884 899	viral infection
T35	KEYPHRASE-NOTYPES 905 917	positive CSF
T36	KEYPHRASE-NOTYPES 919 933	nasopharyngeal
T37	KEYPHRASE-NOTYPES 938 953	rectal cultures
T38	KEYPHRASE-NOTYPES 955 965	poliovirus
T39	KEYPHRASE-NOTYPES 969 984	rectal cultures
T40	KEYPHRASE-NOTYPES 1006 1013	vaccine
T41	KEYPHRASE-NOTYPES 1041 1051	meningitis
